ClinConnect ClinConnect Logo
Search / Trial NCT05854160

Stimulation-Induced Changes in Fronto-Limbic Network

Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · May 2, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Epilepsy Comorbid Mental Health Disorders S Eeg Anxiety Fronto Limbic Network Pavlovian Fear Conditioning Paradigm

ClinConnect Summary

This clinical trial is investigating how our brains process emotions, particularly in people with epilepsy and mental disorders. Researchers will use a special technique called stereoelectroencephalography (sEEG), which involves placing electrodes in the brain to measure activity while also providing brain stimulation. Participants will complete simple tasks related to emotions while the researchers monitor their brain activity. By comparing brain activity before and after stimulation, the study aims to deepen our understanding of how emotions are processed in the brain and to develop new treatment methods in the future.

To be eligible for this trial, participants need to be between 65 and 74 years old, have had sEEG electrodes implanted for epilepsy evaluation, and be capable of understanding and completing simple tasks. They must also have electrodes implanted in specific brain areas related to emotion processing. Participants can expect to engage in straightforward emotion-related tasks while their brain activity is recorded. Importantly, this study is currently recruiting participants, so there is an opportunity for eligible individuals to contribute to this important research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1) implantation of sEEG electrodes for SOC epilepsy surgery evaluation
  • 2) cognitive ability to perform simple tasks and to understand instructions
  • 3) implanted electrodes in the amygdala and medial PFC regions
  • 4) competency to understand and sign a written informed consent.
  • Exclusion Criteria:
  • 1) an inability to complete the task

About University Of Alabama At Birmingham

The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.

Locations

Birmingham, Alabama, United States

Patients applied

0 patients applied

Trial Officials

Adam Goodman, PhD

Principal Investigator

University of Alabama at Birmingham

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported